Loss of the type Ill TGF-β receptor during cancer progression generates an immunotolerant tumor microenvironment: Translational implications for TGF-β inhibition and immunotherapy biomarker development

被引：0
|
作者：
Hanks, Brent A. [1 ]
Holtzhausen, Alisha [1 ]
Gimpel, Petra [2 ]
Campbell, Olivia [1 ]
Jamieson, Rebekah [1 ]
Ling, Leona E. [3 ]
Morse, Michael A. [1 ]
Lyerly, H. K. [1 ]
Blobe, Gerard [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Free Univ Berlin, Berlin, Germany
[3] Biogen Idec Inc, Cambridge, MA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3548
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3548
引用
下载
收藏
页数：1
相关论文
共 45 条
  • [21] The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF-β receptor plus dual checkpoint inhibition maintains antitumor immune cells
    Rana, Manjul
    Kansal, Rita
    Chaib, Mehdi
    Teng, Bin
    Morrrison, Michelle
    Hayes, David Neil
    Stanfill, Ansley G.
    Shibata, David
    Carson, James A.
    Makowski, Liza
    Glazer, Evan S.
    MOLECULAR CARCINOGENESIS, 2022, 61 (06) : 549 - 557
  • [22] Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion
    Galliher, Amy J.
    Schiemann, William P.
    CANCER RESEARCH, 2007, 67 (08) : 3752 - 3758
  • [23] TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity
    Panagi, Myrofora
    Voutouri, Chrysovalantis
    Mpekris, Fotios
    Papageorgis, Panagiotis
    Martin, Margaret R.
    Martin, John D.
    Demetriou, Philippos
    Pierides, Chryso
    Polydorou, Christiana
    Stylianou, Andreas
    Louca, Maria
    Koumas, Laura
    Costeas, Paul
    Kataoka, Kazunori
    Cabral, Horacio
    Stylianopoulos, Triantafyllos
    THERANOSTICS, 2020, 10 (04): : 1910 - 1922
  • [24] TGF-β receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer
    Jovanovic, Bojana
    Beeler, J. Scott
    Pickup, Michael W.
    Chytil, Anna
    Gorska, Agnieszka E.
    Ashby, William J.
    Lehmann, Brian D.
    Zijlstra, Andries
    Pietenpol, Jennifer A.
    Moses, Harold L.
    CANCER RESEARCH, 2015, 75
  • [25] Mechanism of action and efficacy of LY2109761, a TGF-β receptor inhibitor, targeting tumor microenvironment in liver cancer after TACE
    He, Xiaojun
    Guo, Xiaopeng
    Zhang, Hongsen
    Kong, Xiangchuang
    Yang, Fan
    Zheng, Chuansheng
    ONCOTARGET, 2018, 9 (01) : 1130 - 1142
  • [26] Heterogeneous transforming growth factor (TGF)-β unresponsiveness and loss of TGF-β receptor type II expression caused by histone deacetylation in lung cancer cell lines
    Osada, H
    Tatematsu, Y
    Masuda, A
    Saito, T
    Sugiyama, M
    Yanagisawa, K
    Takahashi, T
    CANCER RESEARCH, 2001, 61 (22) : 8331 - 8339
  • [27] Localization of recognition site between transforming growth factor-β1 (TGF-β1) and TGFβ receptor type II:: possible implications in breast cancer
    Ivanovic, V
    Demajo, M
    Todorovic-Rakovic, N
    Nikolic-Vukosavljevic, D
    Neskovic-Konstantinovic, Z
    Krtolica, K
    Veljkovic, V
    Prljic, J
    Dimitrijevic, B
    MEDICAL HYPOTHESES, 2004, 62 (05) : 727 - 732
  • [28] Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy
    Mirlekar, Bhalchandra
    SAGE OPEN MEDICINE, 2022, 10
  • [29] Mechanisms Underlying TGF-β Inhibition of Surfactant Protein-a (SP-A) Expression in Human Fetal Lung: Implications for Development and Cancer
    Benlhabib, Houda
    Guo, Wei
    Mendelson, Carole R.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [30] Eribulin impairs the transport of TGF-13 type I receptor leading to inhibition of downstream non-canonical TGF-β signaling necessary for cancer metastasis and survival
    Rohena, C. C.
    Kaul, R.
    Risinger, A. L.
    Mooberry, S. L.
    CANCER RESEARCH, 2016, 76
12345